Unilever
driving operational excellence cells improving covid response dove nearly of brands seen as more purposeful free cash flow improved penetration innovation design for channel mice growth | Unilever
Company
Deck Type
Sector
Industry
Deck date
February 2021
Slide
26 of 40
Related slides by other companies
Compass Therapeutics
Investor Presentation
May 2023
partial response in a patient with small cell lung cancer i | Compass Therapeutics
Compass Therapeutics
Investor Presentation
February 2023
partial response in a patient with small cell lung cancer a he | Compass Therapeutics
Nestle
Results
March 2024
operational priorities | Nestle
Compass Therapeutics
Investor Presentation
May 2022
partial response in a patient with small cell lung cancer after progression on and | Compass Therapeutics
Other recent decks by Unilever
See all presentations (22 decks)
Results
February 2024
Results
October 2023
Results
July 2023
Investor Conference
June 2023
Search Thousands of Presentations by World Leading Companies
Trending:
Addressable Market
Ecosystem
Beauty Market
WACC
NFT
Management Team
Investment Highlights

Stay in the loop

Join our mailing list to stay in the loop with updates and newest feature releases

Presentations

Start Up
IPO
SPAC
M&A
Investor Day
Results
ESG
Credit
Investment Banking

Explore

Presentation Collections
Slide Collections

Company

Blog
Contact us
© 2021-2024 Slidebook.io